This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2019 Mar;7(3):163-165.

doi: 10.1016/S2213-8587(19)30004-X. Epub 2019 Jan 9.

Hope for patients with X-linked hypophosphataemia?

John M Pettifor¹

Affiliations

Affiliation

¹ SAMRC/Wits Developmental Pathways for Health Research Unit, Department of Paediatrics, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2050, South Africa. Electronic address: john.pettifor@wits.ac.za.

PMID: 30638857
DOI: 10.1016/S2213-8587(19)30004-X

Comment

Hope for patients with X-linked hypophosphataemia?

John M Pettifor. Lancet Diabetes Endocrinol. 2019 Mar.

. 2019 Mar;7(3):163-165.

doi: 10.1016/S2213-8587(19)30004-X. Epub 2019 Jan 9.

Author

John M Pettifor¹

Affiliation

¹ SAMRC/Wits Developmental Pathways for Health Research Unit, Department of Paediatrics, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2050, South Africa. Electronic address: john.pettifor@wits.ac.za.

PMID: 30638857
DOI: 10.1016/S2213-8587(19)30004-X

No abstract available

PubMed Disclaimer

Comment on

Efficacy and safety of burosumab in children aged 1-4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial.
Whyte MP, Carpenter TO, Gottesman GS, Mao M, Skrinar A, San Martin J, Imel EA. Whyte MP, et al. Lancet Diabetes Endocrinol. 2019 Mar;7(3):189-199. doi: 10.1016/S2213-8587(18)30338-3. Epub 2019 Jan 9. Lancet Diabetes Endocrinol. 2019. PMID: 30638856 Clinical Trial.

Similar articles

Panel Discussion: Some Aspects of the Management of Patients with X-Linked Hypophosphataemic Rickets.
Torregrosa JV, Sánchez Del Pozo J, Luiz Yanes MI, Muñoz Torres M. Torregrosa JV, et al. Adv Ther. 2020 May;37(Suppl 2):121-126. doi: 10.1007/s12325-019-01208-w. Epub 2020 Mar 31. Adv Ther. 2020. PMID: 32236878 Review.
Burosumab treatment of children with X-linked hypophosphataemic rickets.
Gordon RJ, Levine MA. Gordon RJ, et al. Lancet. 2019 Jun 15;393(10189):2364-2366. doi: 10.1016/S0140-6736(19)31054-2. Epub 2019 May 16. Lancet. 2019. PMID: 31104830 No abstract available.
[X-linked hypophosphatemic rickets due to mutations in PHEX: Clinical and evolutionary variability].
Martos Moreno GÁ, Aparicio C, de Lucas C, Gil Peña H, Argente J. Martos Moreno GÁ, et al. An Pediatr (Barc). 2016 Jul;85(1):41-3. doi: 10.1016/j.anpedi.2016.04.012. Epub 2016 May 21. An Pediatr (Barc). 2016. PMID: 27221261 Spanish. No abstract available.
Mutational analysis of patients with FGF23-related hypophosphatemic rickets.
Kinoshita Y, Saito T, Shimizu Y, Hori M, Taguchi M, Igarashi T, Fukumoto S, Fujita T. Kinoshita Y, et al. Eur J Endocrinol. 2012 Aug;167(2):165-72. doi: 10.1530/EJE-12-0071. Epub 2012 May 10. Eur J Endocrinol. 2012. PMID: 22577109
Hypophosphatemic rickets and osteomalacia.
de Menezes Filho H, de Castro LC, Damiani D. de Menezes Filho H, et al. Arq Bras Endocrinol Metabol. 2006 Aug;50(4):802-13. doi: 10.1590/s0004-27302006000400025. Arq Bras Endocrinol Metabol. 2006. PMID: 17117305 Review.

See all similar articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science